SARS-CoV-2 variant prediction and antiviral drug design are enabled by RBD in vitro evolution - Nature Microbiology
Evolution of the SARS-CoV-2 spike protein receptor-binding domain in vitro recapitulates SARS-CoV-2 variant emergence and produces an effective antiviral spike receptor-binding domain variant.
www.nature.com